Ignite Creation Date:
2025-12-24 @ 11:46 PM
Ignite Modification Date:
2026-05-08 @ 12:09 AM
Study NCT ID:
NCT01824251
Status:
COMPLETED
Last Update Posted:
2016-01-20
First Post:
2013-04-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.
Sponsor:
Nihon Pharmaceutical Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NPB-01-09/C-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None